Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06455163

Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers

Led by VU University of Amsterdam · Updated on 2024-08-15

102

Participants Needed

1

Research Sites

260 weeks

Total Duration

On this page

Sponsors

V

VU University of Amsterdam

Lead Sponsor

Z

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborating Sponsor

AI-Summary

What this Trial Is About

INTRODUCTION AND RATIONALE It has been estimated that at least 50% of the home living persons with dementia in the Netherlands receive little or no formal care and support (Zorgstandaard Dementie, 2013). Reasons why persons with dementia and their informal caregivers receive no formal care vary, include absence of diagnosis, denial of illness, embarrassment or the complexity of the care and referral system. A common concern among health care professionals is that by the time the person with dementia or informal caregiver do seek or receive formal care it may be too late. The difficulties at home may already be so severe that there is little that community-based care can do and admission to residential care may follow soon after. Appropriate support at an earlier stage may prevent more serious difficulties and postpone admission to residential care. Therefore, health care professionals are looking for strategies to reach persons with dementia and caregivers in an earlier stage of dementia and encourage them to accept some form of help or support. The rationale of this study is to investigate how persons living with dementia and their close others can be encouraged to accept support and whether support at an early stage is effective in preventing severe deterioration in wellbeing, behavioural difficulties and high care costs later on. OBJECTIVES * Estimate the effect of EE on caregiver self-efficacy compared to usual care * Estimate the effect of EE on the total care costs of caregiver and person with dementia compared to usual care * Estimate the cost-effectiveness and cost-utility of EE compared to usual care * Perform a process evaluation to monitor delivery of EE and experiences of persons with dementia, caregivers and care professionals * Explore treatment responsiveness of EE in terms of self-efficacy and quality of life STUDY DESIGN Pragmatic, cluster randomised controlled trial. STUDY POPULATION Informal caregivers and people with early-stage dementia, who are community dwelling and receive little or no dementia-related formal ADL care. INTERVENTION The intervention (Eerder Erbij, EE) is a person-centred, manual-based intervention consisting of education, information and a support group. MAIN STUDY PARAMETERS/ENDPOINTS Primary: self-efficacy. Cost-utility: EQ5D, RUD. Secondary: quality-of-life, caregiver burden. DATA COLLECTION Measurements consist of questionnaires (total duration is approximately 1 hour; administered at home; take place at baseline, 3, 6, and 12 months).

CONDITIONS

Official Title

Eerder Erbij: The Path Towards Offering Timely Support for People With Dementia and Their Caregivers

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Informal caregivers can be spouses, relatives, or friends who care for and support the person with dementia without pay
  • If the caregiver does not live with the person with dementia, they must visit at least 3 times a week
  • The person with dementia must be living at home and cared for by the caregiver
  • The person with dementia should have a diagnosis of dementia or severe cognitive impairments suggesting dementia
  • The person with dementia is not receiving formal personal care related to daily living activities more than once a week
Not Eligible

You will not qualify if you...

  • Major mental or physical illnesses affecting participation, such as major depression or stroke, in either the caregiver or person with dementia
  • Participation in another intervention or similar support program by either the person with dementia or caregiver
  • Dementia caused by HIV, acquired brain impairment, Down syndrome, Huntington's disease, or alcohol abuse
  • Inability to give informed consent
  • Informal caregiver is younger than 18 years old

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Klinische Neuropsychologie

Amsterdam, North Holland, Netherlands, 1081 BT

Actively Recruiting

Loading map...

Research Team

S

Sanne Balvert, Msc.

CONTACT

M

Maarten Milders, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here